乐观
$4.14
情景价格
$1.245
-0.029 (-2.35%)收盘时
AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance.
Airsculpt Technologies Inc is currently not a strong buy due to its low current price of $1.275 and a very low RSI of 11.478, indicating oversold conditions. While analysts have set a price target of $5, the stock has experienced a significant decline of 87.66% over the past year, which raises concerns about its stability. The main risk is its negative earnings per share (EPS) of -0.02, which reflects ongoing financial struggles despite some improvements in gross margin to 54.39%.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

SBS Investigates AirSculpt for Securities Violations

Pomerantz LLP Investigates AirSculpt Securities Fraud Claims

Pomerantz LLP Investigates AirSculpt Securities Fraud Claims

AirSculpt Reports Q2 Earnings: Revenue Decline but Business Stabilization

AirSculpt to Report Q2 2026 Earnings on August 10
AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).
Airsculpt Technologies Inc is currently not a strong buy due to its low current price of $1.275 and a very low RSI of 11.478, indicating oversold conditions. While analysts have set a price target of $5, the stock has experienced a significant decline of 87.66% over the past year, which raises concerns about its stability. The main risk is its negative earnings per share (EPS) of -0.02, which reflects ongoing financial struggles despite some improvements in gross margin to 54.39%.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。